Martín Fabani

Martín Fabani has an extensive work experience in the field of sequencing applications. Currently, they serve as the Vice President at Singular Genomics since March 2022. Prior to this, they held the position of Senior Director at the same company from March 2021 to March 2022. Before joining Singular Genomics, they worked at Verogen as the Director of Product Development from September 2017 to January 2020. Martin also has experience working at Human Longevity, Inc. as the Lead in Sequencing R&D from August 2014 to August 2017. Martín started their career at Illumina, where they held the role of Senior Scientist for a brief period in 2014 and was previously a Scientist II from June 2012 to July 2014. Before joining Illumina, Martin worked as a Senior Scientist at DiThera Inc. from February 2011 to June 2012. Martín'searly career involved positions at the Medical Research Council Laboratory of Molecular Biology, where they served as an Investigator Scientist from August 2008 to February 2011 and as a Career Development Fellow from September 2004 to July 2008.

Martín Fabani completed their education with a PhD in Biochemistry/Medicinal Chemistry from The University of Manchester from 2001 to 2004. Prior to that, they studied Biotechnology at Universidad Nacional de Quilmes from 1995 to 2000.